Your browser doesn't support javascript.
loading
A scoping literature review of global dengue age-stratified seroprevalence data: estimating dengue force of infection in endemic countries.
Vicco, Anna; McCormack, Clare; Pedrique, Belen; Ribeiro, Isabela; Malavige, Gathsaurie Neelika; Dorigatti, Ilaria.
Afiliación
  • Vicco A; Department of Molecular Medicine, University of Padua, Padua, Italy; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Jameel Institute, Imperial College London, London, United Kingdom. Electronic address: a.vicco21@imperial.ac.uk.
  • McCormack C; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Jameel Institute, Imperial College London, London, United Kingdom.
  • Pedrique B; Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland.
  • Ribeiro I; Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland.
  • Malavige GN; Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland.
  • Dorigatti I; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Jameel Institute, Imperial College London, London, United Kingdom. Electronic address: i.dorigatti@imperial.ac.uk.
EBioMedicine ; 104: 105134, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38718682
ABSTRACT

BACKGROUND:

Dengue poses a significant burden worldwide, and a more comprehensive understanding of the heterogeneity in the intensity of dengue transmission within endemic countries is necessary to evaluate the potential impact of public health interventions.

METHODS:

This scoping literature review aimed to update a previous study of dengue transmission intensity by collating global age-stratified dengue seroprevalence data published in the Medline, Embase and Web of Science databases from 2014 to 2023. These data were then utilised to calibrate catalytic models and estimate the force of infection (FOI), which is the yearly per-capita risk of infection for a typical susceptible individual.

FINDINGS:

We found a total of 66 new publications containing 219 age-stratified seroprevalence datasets across 30 endemic countries. Together with the previously available average FOI estimates, there are now more than 250 dengue average FOI estimates obtained from seroprevalence studies from across the world.

INTERPRETATION:

The results show large heterogeneities in average dengue FOI both across and within countries. These new estimates can be used to inform ongoing modelling efforts to improve our understanding of the drivers of the heterogeneity in dengue transmission globally, which in turn can help inform the optimal implementation of public health interventions.

FUNDING:

UK Medical Research Council, Wellcome Trust, Community Jameel, Drugs for Neglected Disease initiative (DNDi) funded by the French Development Agency, Médecins Sans Frontières International; Swiss Agency for Development and Cooperation and UK aid.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dengue Límite: Humans Idioma: En Revista: EBioMedicine Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dengue Límite: Humans Idioma: En Revista: EBioMedicine Año: 2024 Tipo del documento: Article